|
1
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
3
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kerbel RS: Tumor angiogenesis. N Engl J
Med. 358:2039–2049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsu HY, Joos TO and Koga H: Multiplex
microsphere-based flow cytometric platforms for protein analysis
and their application in clinical proteomics-from assays to
results. Electrophoresis. 30:4008–4019. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hiratsuka S: Vasculogenensis, angiogenesis
and special features of tumor blood vessels. Front Biosci (Landmark
Ed). 16:1413–1427. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Yu LK and Xia N: Evaluation of
serum and pleural levels of endostatin and vascular epithelial
growth factor in lung cancer patients with pleural effusion. Asian
Pac J Trop Med. 5:239–242. 2012. View Article : Google Scholar
|
|
9
|
Muramatsu M, Yamamoto S, Osawa T and
Shibuya M: Vascular endothelial growth factor receptor-1 signaling
promotes mobilization of macrophage lineage cells from bone marrow
and stimulates solid tumor growth. Cancer Res. 70:8211–8221. 2010.
View Article : Google Scholar
|
|
10
|
Hiratsuka S, Nakamura K, Iwai S, et al:
MMP9 induction by vascular endothelial growth factor receptor-1 is
involved in lung-specific metastasis. Cancer Cell. 2:289–300. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bremnes RM, Camps C and Sirera R:
Angiogenesis in non-small cell lung cancer: the prognostic impact
of neoangiogenesis and the cytokines VEGF and bFGF in tumours and
blood. Lung Cancer. 51:143–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tas F, Duranyildiz D, Oguz H, Camlica H,
Yasasever V and Topuz E: Serum vascular endothelial growth factor
(VEGF) and bcl-2 levels in advanced stage non-small cell lung
cancer. Cancer Invest. 24:576–580. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jumper C, Cobos E and Lox C: Determination
of the serum matrix metalloproteinase-9 (MMP-9) and tissue
inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with
either advanced small-cell lung cancer or non-small-cell lung
cancer prior to treatment. Resp Med. 98:173–177. 2004. View Article : Google Scholar
|
|
14
|
Katsabeki-Katsafli A, Kerenidi T, Kostikas
K, et al: Serum vascular endothelial growth factor is related to
systemic oxidative stress in patients with lung cancer. Lung
Cancer. 60:271–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng S, Chang Y, Hodges KB, et al:
Expression of KISS1 and MMP-9 in non-small cell lung cancer and
their relations to metastasis and survival. Anticancer Res.
30:713–718. 2010.PubMed/NCBI
|
|
16
|
Yurdakul A, Akyürek N, Yilmaz Ş, Karakaya
J, Memış L and Öztürk C: Prognostic impact of matrix
metalloproteinases (MMP-9 and MMP-2) and vascular endothelial
growth factor expression in non-small cell lung cancer. Turk J Med
Sci. 42:281–288. 2012.
|
|
17
|
Tamura M, Oda M, Matsumoto I, et al: The
combination assay with circulating vascular endothelial growth
factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for
diagnosing lymph node metastasis in patients with non-small cell
lung cancer. Ann Surg Oncol. 11:928–933. 2004. View Article : Google Scholar
|
|
18
|
Laack E, Köhler A, Kugler C, et al:
Pretreatment serum levels of matrix metalloproteinase-9 and
vascular endothelial growth factor in non-small-cell lung cancer.
Ann Oncol. 13:1550–1557. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimanuki Y, Takahashi K, Cui R, Hori S,
Takahashi F, Miyamoto H and Fukurchi Y: Role of serum vascular
endothelial growth factor in the prediction of angiogenesis and
prognosis for non-small cell lung cancer. Lung. 183:29–42. 2005.
View Article : Google Scholar
|
|
20
|
Cox G, Jones JL and O’Byrne KJ: Matrix
metalloproteinase 9 and the epidermal growth factor signal pathway
in operable non-small cell lung cancer. Clin Cancer Res.
6:2349–2355. 2000.PubMed/NCBI
|
|
21
|
Jin Y, Li JP, Tang LY, et al: Protein
expression and significance of VEGF, EGFR and MMP-9 in non-small
cell lung carcinomas. Asian Pac J Cancer Prev. 12:1473–1476.
2011.PubMed/NCBI
|
|
22
|
Hawinkels LJ, Zuidwijk K, Verspaget HW, et
al: VEGF release by MMP-9 mediated heparansulphate cleavage induces
colorectal cancer angiogenesis. Eur J Cancer. 44:1904–1913. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jantus-Lewintre E, Sanmartín E, Sirera R,
et al: Combined VEGF-A and VEGFR-2 concentrations in plasma:
diagnostic and prognostic implications in patients with advanced
NSCLC. Lung Cancer. 74:326–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Atkinson JM, Pennington CJ, Martin SW, et
al: Membrane type matrix metalloproteinases (MMPs) show
differential expression in non-small cell lung cancer (NSCLC)
compared to normal lung: correlation of MMP-14 mRNA expression and
proteolytic activity. Eur J Cancer. 43:1764–1771. 2007. View Article : Google Scholar
|
|
25
|
Farhat FS, Tfayli A, Fakhruddin N, et al:
Expression, prognostic and predictive impact of VEGF and bFGF in
non-small cell lung cancer. Crit Rev Oncol Hematol. 84:149–160.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chakra M, Pujol JL, Lamy PJ, et al:
Circulating serum vascular endothelial growth factor is not a
prognostic factor of non-small cell lung cancer. J Thorac Oncol.
3:1119–1126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fujise N, Nanashima A, Taniguchi Y, et al:
Prognostic impact of cathepsin B and matrix metalloproteinase-9 in
pulmonary adenocarcinomas by immunohistochemical study. Lung
Cancer. 27:19–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Martins SJ, Takagaki TY, Silva AGP, et al:
Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung
adenocarcinoma. Lung Cancer. 64:105–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
